SynthesisBMC cancer2023

Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Huilin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.